LOUISVILLE, Ky. --(BUSINESS WIRE)--Mar. 9, 2026-- Humana Inc. (the “company”) (NYSE: HUM) announced today the completion of its public offering of $1.0 billion in aggregate principal amount of fixed-to-fixed rate junior subordinated notes due 2056, at 6.625 percent of the principal amount (the
LOUISVILLE, Ky. --(BUSINESS WIRE)--Mar. 5, 2026-- Humana Inc. (the “company”) (NYSE: HUM) announced today that it has priced a public offering of $1.0 billion in aggregate principal amount of fixed-to-fixed rate junior subordinated notes due 2056, at 100.000 percent of the principal amount (the
LOUISVILLE, Ky. --(BUSINESS WIRE)--Feb. 26, 2026-- Humana Inc. (NYSE: HUM) announced today that Jim Rechtin, President and Chief Executive Officer, and Celeste Mellet, Chief Financial Officer, will make a presentation to investors at the Leerink Partners Global Healthcare Conference on Tuesday,
